Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-6.01 Insider Own0.87% Shs Outstand66.86M Perf Week-5.41%
Market Cap70.20M Forward P/E- EPS next Y-0.98 Insider Trans0.00% Shs Float66.28M Perf Month38.05%
Income-226.79M PEG- EPS next Q-0.40 Inst Own7.35% Short Float7.77% Perf Quarter-10.26%
Sales37.47M P/S1.87 EPS this Y76.41% Inst Trans-11.41% Short Ratio3.63 Perf Half Y-22.22%
Book/sh1.44 P/B0.73 EPS next Y39.01% ROA-100.76% Short Interest5.15M Perf Year-84.27%
Cash/sh0.79 P/C1.33 EPS next 5Y- ROE-144.33% 52W Range0.71 - 8.20 Perf YTD-44.44%
Dividend Est.- P/FCF- EPS past 5Y23.59% ROI-254.53% 52W High-87.20% Beta2.36
Dividend TTM- Quick Ratio1.13 Sales past 5Y32.87% Gross Margin27.54% 52W Low47.00% ATR (14)0.09
Dividend Ex-Date- Current Ratio1.46 EPS Y/Y TTM-26.33% Oper. Margin-321.85% RSI (14)54.78 Volatility8.69% 8.56%
Employees344 Debt/Eq0.52 Sales Y/Y TTM26.93% Profit Margin-605.26% Recom1.50 Target Price4.93
Option/ShortYes / Yes LT Debt/Eq0.08 EPS Q/Q51.53% Payout- Rel Volume0.49 Prev Close1.08
Sales Surprise3.39% EPS Surprise7.06% Sales Q/Q18.26% EarningsMay 08 AMC Avg Volume1.42M Price1.05
SMA209.73% SMA507.17% SMA200-40.85% Trades Volume700,320 Change-2.78%
Date Action Analyst Rating Change Price Target Change
Jan-05-23Initiated Scotiabank Sector Outperform $4
Dec-12-22Resumed BTIG Research Buy $3.50
Jul-18-22Resumed Oppenheimer Outperform $12
Jun-16-21Initiated BTIG Research Buy $10
Sep-24-20Initiated Ladenburg Thalmann Buy $1.25
Apr-08-20Initiated Oppenheimer Outperform $1.50
Today 08:00AM
May-10-24 08:00AM
May-09-24 12:08PM
03:44AM Loading…
May-08-24 08:58PM
May-01-24 08:00AM
Apr-30-24 04:05PM
Apr-25-24 01:10PM
Apr-24-24 08:00AM
Apr-17-24 08:00AM
Apr-11-24 08:00AM
01:44PM Loading…
Apr-04-24 01:44PM
Apr-03-24 08:00AM
Apr-02-24 08:00AM
Mar-19-24 08:00AM
Mar-07-24 11:47AM
Mar-06-24 06:44AM
Mar-05-24 11:51PM
Feb-29-24 08:00AM
Feb-28-24 08:01AM
Feb-22-24 08:00AM
Feb-07-24 01:10PM
08:00AM Loading…
Jan-31-24 08:00AM
Jan-30-24 08:00AM
Jan-25-24 08:00AM
Jan-24-24 08:00AM
Jan-23-24 08:00AM
Jan-19-24 08:00AM
Jan-17-24 05:53AM
Jan-11-24 04:01PM
Jan-10-24 08:00AM
Jan-08-24 08:00AM
Jan-03-24 08:00AM
Dec-28-23 08:00AM
Dec-26-23 08:00AM
Dec-14-23 08:00AM
Dec-12-23 08:00AM
Dec-06-23 08:00AM
Dec-05-23 06:00AM
Nov-30-23 08:00AM
Nov-29-23 10:04AM
Nov-17-23 09:35AM
Nov-15-23 12:07AM
Nov-14-23 08:00AM
Nov-10-23 05:00AM
Nov-09-23 10:36AM
Nov-08-23 08:00PM
Nov-02-23 08:00AM
Nov-01-23 04:05PM
Oct-27-23 12:28PM
Oct-26-23 10:02AM
Oct-11-23 08:05AM
Sep-28-23 08:00AM
Sep-22-23 04:05PM
Sep-21-23 12:00PM
Sep-14-23 08:00AM
Sep-11-23 04:06AM
Sep-06-23 08:00AM
Sep-04-23 07:00AM
Aug-30-23 08:00AM
Aug-28-23 10:22AM
Aug-21-23 04:05PM
Aug-16-23 08:00AM
Aug-14-23 06:17PM
Aug-11-23 08:00AM
Aug-10-23 06:41PM
Aug-09-23 08:30PM
Aug-04-23 12:00PM
Aug-02-23 08:00AM
Aug-01-23 05:30AM
Jul-31-23 08:00AM
Jul-27-23 08:00AM
Jul-05-23 06:08PM
Jun-29-23 05:09PM
Jun-26-23 05:14PM
Jun-21-23 08:41PM
Jun-20-23 08:00AM
Jun-15-23 06:38AM
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mamuszka HannahDirectorJun 13 '23Buy0.7665,78950,00065,789Jun 14 06:32 PM